共 303 条
[1]
Bottai M(2017)EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report RMD Open 3 e000507-374
[2]
Tjarnlund A(1991)A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups Medicine (Baltimore) 70 360-529
[3]
Santoni G(2007)Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance Curr Opin Rheumatol 19 523-340
[4]
Werth VP(2008)Autoantibodies and their significance in myositis Curr Rheumatol Rep 10 333-194
[5]
Pilkington C(2017)Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia Respir Med 132 189-64
[6]
de Visser M(2017)The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies Respir Med 127 57-99
[7]
Alfredsson L(2016)Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease Respir Med 121 91-32
[8]
Amato AA(2017)Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease Respir Investig 55 24-26564
[9]
Barohn RJ(2017)Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis Oncotarget 8 26552-13
[10]
Liang MH(2018)Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody Respir Med 141 7-2200